Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
N Engl J Med ; 357(13): 1281-92, 2007 Sep 27.
Artículo en Inglés | MEDLINE | ID: mdl-17898097

RESUMEN

BACKGROUND: It has been hypothesized that early exposure to thimerosal, a mercury-containing preservative used in vaccines and immune globulin preparations, is associated with neuropsychological deficits in children. METHODS: We enrolled 1047 children between the ages of 7 and 10 years and administered standardized tests assessing 42 neuropsychological outcomes. (We did not assess autism-spectrum disorders.) Exposure to mercury from thimerosal was determined from computerized immunization records, medical records, personal immunization records, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We assessed the association between current neuropsychological performance and exposure to mercury during the prenatal period, the neonatal period (birth to 28 days), and the first 7 months of life. RESULTS: Among the 42 neuropsychological outcomes, we detected only a few significant associations with exposure to mercury from thimerosal. The detected associations were small and almost equally divided between positive and negative effects. Higher prenatal mercury exposure was associated with better performance on one measure of language and poorer performance on one measure of attention and executive functioning. Increasing levels of mercury exposure from birth to 7 months were associated with better performance on one measure of fine motor coordination and on one measure of attention and executive functioning. Increasing mercury exposure from birth to 28 days was associated with poorer performance on one measure of speech articulation and better performance on one measure of fine motor coordination. CONCLUSIONS: Our study does not support a causal association between early exposure to mercury from thimerosal-containing vaccines and immune globulins and deficits in neuropsychological functioning at the age of 7 to 10 years.


Asunto(s)
Desarrollo Infantil/efectos de los fármacos , Inteligencia/efectos de los fármacos , Conservadores Farmacéuticos/farmacología , Timerosal/farmacología , Niño , Discapacidades del Desarrollo/inducido químicamente , Discapacidades del Desarrollo/epidemiología , Discapacidades del Desarrollo/prevención & control , Exposición a Riesgos Ambientales/análisis , Compuestos de Etilmercurio/efectos adversos , Compuestos de Etilmercurio/análisis , Compuestos de Etilmercurio/farmacología , Femenino , Humanos , Inmunoglobulinas/administración & dosificación , Inmunoglobulinas/química , Lactante , Recién Nacido , Masculino , Pruebas Neuropsicológicas , Embarazo , Efectos Tardíos de la Exposición Prenatal , Conservadores Farmacéuticos/efectos adversos , Análisis de Regresión , Timerosal/efectos adversos , Vacunas/efectos adversos , Vacunas/química
2.
Artículo en Inglés | MEDLINE | ID: mdl-17085843

RESUMEN

Identifying common patterns among area cladograms that arise in historical biogeography is an important tool for biogeographical inference. We develop the first rigorous formalization of these pattern-identification problems. We develop metrics to compare area cladograms. We define the maximum agreement area cladogram (MAAC) and we develop efficient algorithms for finding the MAAC of two area cladograms, while showing that it is NP-hard to find the MAAC of several binary area cladograms. We also describe a linear-time algorithm to identify if two area cladograms are identical.


Asunto(s)
Algoritmos , Demografía , Modelos Genéticos , Reconocimiento de Normas Patrones Automatizadas/métodos , Filogenia , Dinámica Poblacional , Simulación por Computador
3.
Eval Rev ; 30(5): 556-76, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16966676

RESUMEN

There is a widespread belief that high-quality early care and education can improve children's school readiness. However, debate continues about the essential elements of a high-quality experience, about whether quality means the same things across different types of care settings, about how to measure quality, and about the level of quality that might make a meaningful difference in outcomes for children. Are the aspects of the child care environment that researchers measure the ones that are most strongly related to children's development? This article argues that the ways in which researchers currently measure early care environments are flawed and that the conclusions drawn about the relationship between these measures and outcomes for children are frequently incorrect or overstated. The article addresses four questions: How is the quality of the child care environment commonly defined and measured? Do the most commonly used measures capture the child's experience? Do they work well across all settings? Are researchers drawing the correct conclusions from studies that relate the child care environment to child outcomes? Finally, the article discusses some possible directions for future research.


Asunto(s)
Guarderías Infantiles/normas , Intervención Educativa Precoz/normas , Evaluación de Resultado en la Atención de Salud/métodos , Evaluación de Programas y Proyectos de Salud/métodos , Medio Social , Factores de Edad , Desarrollo Infantil , Preescolar , Escolaridad , Humanos , Lactante , Psicometría , Garantía de la Calidad de Atención de Salud , Factores de Tiempo , Estados Unidos
4.
Pediatrics ; 132 Suppl 2: S180-90, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24187122

RESUMEN

Home visiting programs have been successful in engaging and enrolling families who are at high risk for stress, depression, and substance abuse. However, many of these mothers may not be receiving mental health services because home visitors lack the knowledge and skills to identify mental health or determine how to appropriately address these problems. In response, a growing number of home visiting programs are expanding their capacity by integrating a mental health provider into their ongoing operations. This approach, referred to as early childhood mental health consultation, involves a partnership between a professional consultant with early childhood mental health expertise and home visiting or family support programs, staff, and families. This integrated model holds the promise of promoting parent and child behavioral health by enhancing the capacity of home visitors to identify and appropriately address the unmet mental health needs of children and families. The article highlights efforts under way in several federally funded Linking Actions for Unmet Needs in Children's Health Project sites where local programs are testing the effectiveness of this model.


Asunto(s)
Protección a la Infancia/psicología , Visita Domiciliaria , Salud Mental , Derivación y Consulta , Niño , Depresión/diagnóstico , Depresión/psicología , Depresión/terapia , Humanos
5.
Pediatrics ; 126(4): 656-64, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20837594

RESUMEN

OBJECTIVE: Exposure to thimerosal, a mercury-containing preservative that is used in vaccines and immunoglobulin preparations, has been hypothesized to be associated with increased risk of autism spectrum disorder (ASD). This study was designed to examine relationships between prenatal and infant ethylmercury exposure from thimerosal-containing vaccines and/or immunoglobulin preparations and ASD and 2 ASD subcategories: autistic disorder (AD) and ASD with regression. METHODS: A case-control study was conducted in 3 managed care organizations (MCOs) of 256 children with ASD and 752 controls matched by birth year, gender, and MCO. ASD diagnoses were validated through standardized in-person evaluations. Exposure to thimerosal in vaccines and immunoglobulin preparations was determined from electronic immunization registries, medical charts, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We used conditional logistic regression to assess associations between ASD, AD, and ASD with regression and exposure to ethylmercury during prenatal, birth-to-1 month, birth-to-7-month, and birth-to-20-month periods. RESULTS: There were no findings of increased risk for any of the 3 ASD outcomes. The adjusted odds ratios (95% confidence intervals) for ASD associated with a 2-SD increase in ethylmercury exposure were 1.12 (0.83-1.51) for prenatal exposure, 0.88 (0.62-1.26) for exposure from birth to 1 month, 0.60 (0.36-0.99) for exposure from birth to 7 months, and 0.60 (0.32-0.97) for exposure from birth to 20 months. CONCLUSIONS: In our study of MCO members, prenatal and early-life exposure to ethylmercury from thimerosal-containing vaccines and immunoglobulin preparations was not related to increased risk of ASDs.


Asunto(s)
Trastorno Autístico/inducido químicamente , Efectos Tardíos de la Exposición Prenatal , Conservadores Farmacéuticos/efectos adversos , Timerosal/efectos adversos , Vacunas/efectos adversos , Adolescente , Trastorno Autístico/diagnóstico , Estudios de Casos y Controles , Niño , Compuestos de Etilmercurio/efectos adversos , Femenino , Humanos , Inmunoglobulinas Intravenosas/efectos adversos , Lactante , Recién Nacido , Masculino , Embarazo , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda